Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Kathleen Bickel to Neoplasms

This is a "connection" page, showing publications Kathleen Bickel has written about Neoplasms.

 
Connection Strength
 
 
 
0.766
 
  1. Bickel KE, Levy C, MacPhee ER, Brenner K, Temel JS, Arch JJ, Greer JA. An Integrative Framework of Appraisal and Adaptation in?Serious Medical Illness. J Pain Symptom Manage. 2020 09; 60(3):657-677.e6.
    View in: PubMed
    Score: 0.275
  2. Bickel KE, McNiff K, Buss MK, Kamal A, Lupu D, Abernethy AP, Broder MS, Shapiro CL, Acheson AK, Malin J, Evans T, Krzyzanowska MK. Defining High-Quality Palliative Care in Oncology Practice: An American Society of Clinical Oncology/American Academy of Hospice and Palliative Medicine Guidance Statement. J Oncol Pract. 2016 09; 12(9):e828-38.
    View in: PubMed
    Score: 0.212
  3. Power S, Bickel K, Chen RC, Chiang AC, Garrett-Mayer L, Makhoul I, Mougalian SS, Shapiro CL, Siegel R, Smith C, Rocque GB, Kozlik MM, Crist STS, Kamal A. Associations of Early Completion of Advance Directives With Key End-of-Life Quality Measures: Analysis of an ASCO Quality Oncology Practice Initiative Patient Cohort. JCO Oncol Pract. 2023 04; 19(4):e520-e526.
    View in: PubMed
    Score: 0.083
  4. Cinar P, Cox J, Kamal A, Bickel K, Krzyzanowska M, Armitage J, Ganti AK, Ward J, Wong S, Lonial S, Bosserman L. Oncology Care Delivery in the COVID-19 Pandemic: An Opportunity to Study Innovations and Outcomes. JCO Oncol Pract. 2020 08; 16(8):431-434.
    View in: PubMed
    Score: 0.069
  5. Bluhm M, Connell CM, De Vries RG, Janz NK, Bickel KE, Silveira MJ. Paradox of Prescribing Late Chemotherapy: Oncologists Explain. J Oncol Pract. 2016 12; 12(12):e1006-e1015.
    View in: PubMed
    Score: 0.053
  6. Bluhm M, Connell CM, Janz N, Bickel K, DeVries R, Silveira M. Oncologists' End of Life Treatment Decisions. J Appl Gerontol. 2017 Apr; 36(4):416-440.
    View in: PubMed
    Score: 0.053
  7. Licitra EJ, Vyas V, Nelson K, Musanti R, Beers S, Thomas C, Poplin E, Smith S, Lin Y, Schaaf LJ, Aisner J, Gounder M, Rajendra R, Saleem A, Toppmeyer D, Rubin EH. Phase I evaluation of sequential topoisomerase targeting with irinotecan/cisplatin followed by etoposide in patients with advanced malignancy. Clin Cancer Res. 2003 May; 9(5):1673-9.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)